Cinven’s Acquisition of Amara NZero

Clifford Chance has advised Cinven on the deal. International private equity firm Cinven announced the acquisition of a majority stake in Amara NZero from ProA Capital. Amara...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Abdera’s $142 Million Financing

Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here